Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:2.7.7.8 (polynucleotide phosphorylase)
723 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The disappearance of ribosomes in Escherichia coli cells starved for a carbon source was studied. We used a series of mutants, some of them lacking in ribonuclease I(RNase I, EC 2.7.7.17), and other containing various combinations of modified polynucleotide phosphorylase (PNPase, EC 2.7.7.8) and modified ribonuclease II (RNase II, EC 3.1.4.1). RNA was prepared from the starved mutant cells and separated on polyacrylamide gels. The results obtained indicate that 23 S RNA degradation is similar in all strains that lack RNase I, and is slightly increased in the strain that contains this enzyme. The extent of 16 S RNA degradation is identical in all strains tested. RNA species in the size of 4 S and smaller accumulate in mutants containing modified forms of PNPase and RNase II. The appearance of an RNA species 10% smaller than 16 S RNA (d16 S RNA) was observed in all strains that contain unmodified RNase II. Analysis of ribosomes and polysomes and their RNA content indicated that polysomes are converted to monosomes and these, in turn, to ribosomal subunits. No RNA degradation products were found in polysomes, 70 S, OR 50 C particle; 30 S subunits contained 16 S RNA as well as the d16 S RNA species. Subunits are degraded to a similar extent in all strains lacking RNase I, and at a slightly faster rate in the strain that contains RNase I. The RNA to protein ratio in subunits prepared from starved cells is similar to that of unstarved cultures. Very little degradation of ribosomal proteins occurs in these mutants during carbon starvation. The proteins released from degraded ribosomes are found in the fast sedimenting (20,000 times g) pellet. Cell viability studies indicated a direct correlation between the capacity of the mutants to recovery from starvation and their capacity to degrade RNA. Thus a biological necessity for degradation of ribosomes during starvation is implied. Based on these data we propose that the endonucleolytic degradation of ribosomal RNA is the primary event in starvation degradation. It takes place in ribosomal subunits, which fall apart after the endonucleoltic attack. The RNA pieces produced by this cleavage are degraded to nucleotide by RNase II and PNPase. The ribosomal proteins attach to the cell membrane.
...
PMID:The fate of ribosomes in Escherichia coli cells starved for a carbon source. 108 66

The purine nucleoside phosphorylases (PNPases) from human and rat erythrocytes and bovine spleen have been subjected to isoelectric focusing. The crystalline bovine spleen PNPase emerged as a single peak of pI = 5.4 whereas the rat erythrocytic PNPase was distributed into two variants of pI = 5.6 and 5.7 and the crystalline human erythrocytic enzyme produced six variants ranging from pI = 5.85 to 6.25. Treatment of human erythrocytic PNPase with dithiobisnitrobenzoate changed the enzyme to a more acidic form (pI = 5.05). The kinetic behaviors of these electrophoretic variants were studied and compared with the unresolved bovine erythrocytic PNPase. All six variants of the human erythrocytic PNPase and the two variants of rat erythrocytic PNPase displayed substrate activation at high concentrations of inosine and deoxyinosine. Bovine erythrocytic PNPase did not show activation with any of the nucleosides whereas with the bovine spleen enzyme activation occurred only with the deoxynucleosides, deoxyinosine and deoxyguanosine. The Km values for inosine, deoxyinosine, guanosine, deoxyguanosine, guanine, and hypoxanthine, where determined, ranged from 1.3 x 10-5 to 3.0 x 10-5 M for all the enzymes except the rat erythrocytic PNPase variants which have higher Km values for inosine (5.9 x 10-5 M, 8.3 x 10-5 M) and deoxyinosine (13 x 10-5 M, 20 x 10-5 M).
...
PMID:Purine nucleoside phosphorylase. Microheterogeneity and comparison of kinetic behavior of the enzyme from several tissues and species. 110 94

We review recent evidence on the in vivo and in vitro mRNA degradation properties of 2 3'-exonucleases, ribonuclease II and polynucleotide phosphorylase. Although secondary structures in the RNA can act as protective barriers against 3' exonucleolytic degradation, it appears that this effect depends on the stability of these structures. The fact that RNase II is more sensitive to RNA secondary structure than PNPase, could account for some differences observed in messenger degradation by the 2 enzymes in vivo. Terminator stem-loop structures are often very stable and 3' exonucleolytic degradation proceeds only after they have been eliminated by an endonucleolytic cleavage. Other secondary structures preceding terminator stem-loop seem to contribute to mRNA stability against exonucleolytic decay.
...
PMID:Different specificities of ribonuclease II and polynucleotide phosphorylase in 3'mRNA decay. 176 98

CI-972 (2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2- d]pyrimidin-4-one monohydrochloride, monohydrate) is a competitive inhibitor of PNPase (E.C. 2.4.2.1., Ki = 0.83 microM) entering clinical trials as a T cell-selective immunosuppressive agent. Neither CI-972 (less than or equal to 50 microM) nor dGuo (less than or equal to 10 microM) inhibited [3H]Thd uptake by human MOLT-4 (T cell) or MGL-8 (B cell) lymphoblasts, but in the presence of 10 microM dGuo, the IC50 for CI-972 decreased to 3.0 microM for MOLT-4 but remained at greater than 50 microM for MGL-8. Inhibition of MOLT-4 growth was associated with an increase in dGTP that was dependent on CI-972 concentration and inhibited by 2'-deoxycytidine. Growth could not be restored by hypoxanthine or adenine. No alterations in GTP pools were noted in MOLT-4, and neither GTP nor dGTP were altered in MGL-8.
...
PMID:Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972. 190 35

We review recent evidence on the in vivo and in vitro mRNA degradation properties of 2 3'-exonucleases, ribonuclease II and polynucleotide phosphorylase. Although secondary structures in the RNA can act as protective barriers against 3' exonucleolytic degradation, it appears that this effect depends on the stability of these structures. The fact that RNase II is more sensitive to RNA secondary structure than PNPase, could account for some differences observed in messenger degradation by the 2 enzymes in vivo. Terminator stem-loop structures are often very stable and 3' exonucleolytic degradation proceeds only after they have been eliminated by an endonucleolytic cleavage. Other secondary structures preceding terminator stem-loop seem to contribute to mRNA stability against exonucleolytic decay.
...
PMID:Different specificities of ribonuclease II and polynucleotide phosphorylase in 3'mRNA decay. 208 42

We have studied the kinetics of guanine incorporation into DNA in mouse T-lymphoma (S-49) mutant cells [PNPase (purine-nucleoside phosphorylase)- and HGPRTase (hypoxanthine: guanine phosphoribosyltransferase)-deficient] that are incapable of converting dGuo (deoxyguanosine) to Gua (guanine) ribonucleotides. Of the two possible pathways for an exogenous guanine source to reach DNA, firstly: dGuo----dGMP----dGDP----dGTP and secondly: Gua----GMP----GDP----dGDP----dGTP only the second pathway was found to be functional in providing guanine for DNA replication, although deoxyguanosine readily produced toxic cellular dGTP levels via the first pathway. The functional guanine-nucleotide-precursor pools for DNA are rather small; further, the depletion of the small GMP pool, but not that of GDP, GTP and dGTP, correlated well with the inhibition of DNA synthesis by mycophenolic acid, an IMP dehydrogenase inhibitor. These results support the hypothesis that guanine-nucleotide incorporation into DNA is highly compartmentalized and that a small functional guanine-nucleotide pool, e.g., the GMP pool, may serve a crucial role in limiting the availability of DNA precursor substrate.
...
PMID:Compartmentation of guanine nucleotide precursors for DNA synthesis. 242 29

Two types of mutants lacking the second purine nucleoside phosphorylase (PNPase 2) activity were isolated using the Escherichia coli K-12 pndR strains with constitutive or inosine-inducible synthesis of the PNPase 2. The mutations of the first type are recessive to the pndR+ allele on the F' episome. They are closely linked to the original pndR+ mutations and therefore affect the pndR gene encoding the activator protein. The mutations of the second type affect the PNPase 2 structural gene (pndA) and are recessive to the pndA+ allele on the F' episome. The nupC-pndR-pndA-ptsH-cysA gene order was established by means of four- and five-factorial transductional crosses.
...
PMID:[Genetic analysis of Escherichia coli K-12 mutants defective for the structural and regulatory genes for second purine nucleoside phosphorylase]. 309 87

Restoration of the ability to catabolise the purine nucleosides in phenotypic revertants of Escherichia coli K-12 mutants defective in deoD encoded purine nucleoside phosphorylase (PNPase 1) is the result of regulatory pndR mutations for synthesis of a second purine nucleoside phosphorylase (PNPase 2). In pndR+ strains synthesis of PNPase 2 is induced by xanthosine; in pndR mutants catabolising all purine nucleosides synthesis of this enzyme is constitutive; in other pndR mutants only catabolising some of purine nucleosides, this catabolisible nucleosides, namely, deoxyinosine, deoxyadenosine as well as, in some cases, inosine and adenosine, act as inducers of PNPase 2 synthesis. In some pndR mutants with inducible PNPase 2, xanthosine is a stronger inducer, in others it is weaker, in comparison with pndR+ strains. In bacterial cells PNPase 2 catalyses the phosphorolytic cleavage of adenosine, inosine, deoxyinosine, guanosine, deoxyguanosine and xanthosine, though in crude extracts adenosine and deoxyadenosine phosphorylase activities of the enzyme are not expressed.
...
PMID:[Regulatory mutants for the synthesis of a 2d purine nucleoside phosphorylase in Escherichia coli K-12. I. Synthesis inducers and the substrate specificity of purine nucleoside phosphorylase in pndR mutants]. 643 6

The reversed-phase mode of high-performance liquid chromatography (HPLC) was used to assay purine nucleoside phosphorylase (PNPase E.C. 2.4.2.1) in human erythrocytes. The reaction conditions were optimized with respect to pH, concentration of enzyme, concentration of substrate and time. In this method, a sample of erythrocytes was incubated with substrate and necessary cofactors. After termination of the reaction, both the decrease in substrate and the increase in product were measured. HPLC is highly suitable for PNPase as both the forward and reverse reactions can be monitored. The complete separation of products from reactants allows the determination of any competing or side reactions.
...
PMID:Optimized assay for purine nucleoside phosphorylase by reversed-phase high-performance liquid chromatography. 677 85

Poly-5-dimethylaminouridylic acid, (poly(Me2N5U)) has been synthesized by the conversion of 5-bromouridine-5'-monophosphate to 5-dimethylaminouridine-5'-monophosphate which was later made into the 5'-diphosphate and subsequently polymerized by PNPase. The polymer formed a 1:1 hybrid with poly(A) with the ability to induce the production of interferon in chick embryoes as certain doses of the hybrid protected chick embryoes against wesselsbron virus (H 10964).
...
PMID:Synthesis and biological activity of polyriboadenylic acid: polyribo-5-dimethylaminouridylic acid hybrid (poly(A): poly(Me2N5U)). 686 39


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>

---